Low median fluorescence intensity could be a nonsafety concept of immunologic risk evaluation in patients with shared molecular eplets in kidney transplantation.

[1]  M. González-Escribano,et al.  Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  R. Duquesnoy.  The antibody response to an HLA mismatch: a model for nonself–self discrimination in relation to HLA epitope immunogenicity , 2012, International journal of immunogenetics.

[3]  A. Amoroso,et al.  Brief report: Why did two patients who type for HLA-B13 have antibodies that react with all Bw4 antigens except HLA-B13? , 2011, Transplant immunology.

[4]  R. Duquesnoy.  Antibody-reactive epitope determination with HLAMatchmaker and its clinical applications. , 2011, Tissue antigens.

[5]  P. Archdeacon,et al.  Summary of FDA Antibody‐Mediated Rejection Workshop , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[6]  D. Roelen,et al.  Challenging the golden standard in defining donor-specific antibodies: does the solid phase assay meet the expectations? , 2011, Tissue antigens.

[7]  F. Claas,et al.  Human Monoclonal Antibody Reactivity With Human Leukocyte Antigen Class I Epitopes Defined by Pairs of Mismatched Eplets and Self-Eplets , 2010, Transplantation.

[8]  A. Minguela,et al.  Specific "intra-allele" and "intra-broad antigen" human leukocyte antigen alloantibodies in kidney graft transplantation. , 2010, Human immunology.

[9]  V. D’Agati,et al.  Sensitivity, specificity and clinical relevance of different cross-matching assays in deceased-donor renal transplantation. , 2008, Transplant immunology.

[10]  M. Christiaans,et al.  Luminex donor-specific crossmatches. , 2008, Tissue antigens.

[11]  T. Larson,et al.  Transplant Glomerulopathy: Subclinical Incidence and Association with Alloantibody , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[12]  C. Haisch,et al.  Extremely High Association Between Appearance of HLA Antibodies and Failure of Kidney Grafts in a Five‐Year Longitudinal Study , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[13]  P. Terasaki,et al.  The Importance of Anti‐HLA‐Specific Antibody Strength in Monitoring Kidney Transplant Patients , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[14]  Medhat Askar,et al.  HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ, and HLA-DP. , 2007, Human immunology.

[15]  A. Minguela,et al.  Pre-formed donor-specific alloantibodies (DSA) detected only by luminex technology using HLA-coated microspheres and causing acute humoral rejection and kidney graft dysfunction. , 2006, Clinical transplants.

[16]  A. Minguela,et al.  Liver recipients harbouring anti-donor preformed lymphocytotoxic antibodies exhibit a poor allograft survival at the first year after transplantation: experience of one centre. , 2005, Transplant immunology.

[17]  S. Llorente,et al.  Acute vascular rejection mediated by HLA antibodies in a cadaveric kidney recipient: discrepancies between FlowPRA, ELISA and CDC vs luminex screening. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[18]  D. Roelen,et al.  THE NUMBER OF AMINO ACID TRIPLET DIFFERENCES BETWEEN PATIENT AND DONOR IS PREDICTIVE FOR THE ANTIBODY REACTIVITY AGAINST MISMATCHED HUMAN LEUKOCYTE ANTIGENS1 , 2004, Transplantation.

[19]  P. Terasaki,et al.  Predicting Kidney Graft Failure by HLA Antibodies: a Prospective Trial , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[20]  D. DeLuca,et al.  HistoCheck: rating of HLA class I and II mismatches by an internet-based software tool , 2004, Bone Marrow Transplantation.

[21]  Rene J. Duquesnoy,et al.  HLA MATCHMAKER: A MOLECULARLY BASED ALGORITHM FOR HISTOCOMPATIBILITY DETERMINATION , 2003 .